Order Article Reprints

Haertel F, Lehmann T, Heller T, Fritzenwanger M, Pfeifer R, Kretzschmar D, Otto S, Bogoviku J, Westphal J, Bruening C, et al. Impact of a VA–ECMO in Combination with an Extracorporeal Cytokine Hemadsorption System in Critically Ill Patients with Cardiogenic Shock–Design and Rationale of the ECMOsorb Trial. Journal of Clinical Medicine. 2023; 12(15):4893. https://doi.org/10.3390/jcm12154893

Haertel, Franz, Thomas Lehmann, Tabitha Heller, Michael Fritzenwanger, Ruediger Pfeifer, Daniel Kretzschmar, Sylvia Otto, Jurgen Bogoviku, Julian Westphal, Christiane Bruening, and et al. 2023. "Impact of a VA–ECMO in Combination with an Extracorporeal Cytokine Hemadsorption System in Critically Ill Patients with Cardiogenic Shock–Design and Rationale of the ECMOsorb Trial" Journal of Clinical Medicine 12, no. 15: 4893. https://doi.org/10.3390/jcm12154893

Haertel, F., Lehmann, T., Heller, T., Fritzenwanger, M., Pfeifer, R., Kretzschmar, D., Otto, S., Bogoviku, J., Westphal, J., Bruening, C., Gecks, T., Kaluza, M., Moebius-Winkler, S., & Schulze, P. C. (2023). Impact of a VA–ECMO in Combination with an Extracorporeal Cytokine Hemadsorption System in Critically Ill Patients with Cardiogenic Shock–Design and Rationale of the ECMOsorb Trial. Journal of Clinical Medicine, 12(15), 4893. https://doi.org/10.3390/jcm12154893